Point-Counterpoint: Is AI Ready for Widespread Mammography Screening?

A point-counterpoint in AJR debates wide AI use in mammography screening. Pro: RCTs show diagnostic gains, AI can reduce second-reader needs and speed workflow. Con: Most evidence from 2D not DBT, no mortality reduction, legal concerns. The tech imperative likely prevails.

• Skeptical view: most performance gains are in 2D mammography and may not apply to DBT; no mortality reduction evidence; legal implications of AI misses are a practical barrier.
• Pro view: evidence from MASAI RCT and PRAIM population study; U.S. studies with DBT show cancer detection gains comparable to Europe; AI could autonomously report some exams to improve workflow.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.